Maithili Life Sciences to Exhibit at CPHI Korea 2024
Maithili Life Sciences is thrilled to announce our participation in the CPHI Korea event in Seoul, South Korea, from August 27th to 29th, 2024. This event marks another step in our mission to become the leading supplier of high-quality Active Pharmaceutical Ingredients (APIs) and intermediates in the South Korean market.
Our Commitment to the South Korean Market
We are dedicated to providing top-quality APIs and intermediates that meet the stringent standards of the South Korean pharmaceutical industry. Our products adhere to international regulatory standards, including PMDA, cGMP, EU-GMP, and WHO-GMP, ensuring they meet the highest benchmarks of safety, efficacy, and reliability.
Why choose Maithili Life Sciences?
- Top-Quality Manufacturing:
Our state-of-the-art facilities and cutting-edge technologies produce APIs and intermediates of the highest quality. - Innovative R&D:
Our dedicated R&D team continually develops new and improved APIs, keeping us at the forefront of pharmaceutical advancements. - Cost-Effective Solutions:
We offer competitive pricing without compromising on quality, providing our clients with cost-effective solutions. - Reliable Supply Chain:
Our robust logistics network ensures timely delivery and consistent availability of our products.
Extensive Product Portfolio
Our comprehensive range of APIs and intermediates includes products across various therapeutic categories, such as:
- Azilsartan Medoxomil Potassium Salt: An angiotensin II receptor antagonist used to treat high blood pressure.
- Benazepril HCl: An ACE inhibitor for treating hypertension.
- Irbesartan: Used to treat high blood pressure and diabetic nephropathy.
- Nebivolol HCl: A beta-blocker that treats high blood pressure.
- Telmisartan: An angiotensin receptor blocker (ARB) for managing hypertension.
- Brivaracetam: Used as an anticonvulsant for epilepsy.
- Modafinil: Promotes wakefulness in conditions like narcolepsy.
- Rasagiline Mesylate: Used in the treatment of Parkinson’s disease.
- Trazodone: An antidepressant used for major depressive disorder.
- Ornidazole: An antibiotic used to treat infections caused by anaerobic bacteria and protozoa.
- Favipiravir: An antiviral used to treat influenza and COVID-19.
- Voriconazole: An antifungal medication for serious fungal infections.
- Etoricoxib: A COX-2 inhibitor for osteoarthritis and rheumatoid arthritis.
- Zaltoprofen: A non-steroidal anti-inflammatory drug (NSAID).
- Cabergoline Intermediates: Used in the treatment of hyperprolactinemia and pituitary tumors.
- Dabigatran Etexilate Mesylate: An anticoagulant used to prevent strokes and blood clots.
- Darolutamide Intermediates: Used in the treatment of non-metastatic castration-resistant prostate cancer.
- Minoxidil: Primarily used for its ability to promote hair growth.
- Dapoxetine HCl: Used for treating premature ejaculation.
- Solifenacin Succinate: Used to treat overactive bladder.
- Sumatriptan Succinate: For the treatment of migraine headaches.
- Tadalafil: Used to treat erectile dysfunction and benign prostatic hyperplasia.
- Tamsulosin: Treats benign prostatic hyperplasia.
- Ticagrelor: An antiplatelet medication to reduce cardiovascular events.
- Torsemide: A diuretic for treating edema and hypertension.
- Sildenafil: Treats erectile dysfunction and pulmonary arterial hypertension.
- Vardenafil: Used to treat erectile dysfunction.
Strategic Expansion in South Korea
Our strategic initiatives in South Korea include:
Localized Support:
Establishing dedicated support teams in South Korea to provide tailored assistance to our clients, ensuring prompt and efficient service.
Regulatory Compliance:
Ensuring our products meet the regulatory standards of the Ministry of Food and Drug Safety (MFDS) in South Korea, reinforcing our commitment to quality and compliance.
Partnerships and Collaborations:
Building strong relationships with local distributors and pharmaceutical companies to expand our reach and enhance our service capabilities, making us the preferred API supplier in the region.
Contact Us
For more information about Maithili Life Sciences and our extensive range of APIs and intermediates, please contact us at [email protected] or visit our website www.maithililifesciences.com.
Maithili Life Sciences: Your Trusted Partner for High-Quality APIs and Intermediates in South Korea
Join us at CPHI Korea 2024 and discover how Maithili Life Sciences is leading the way in pharmaceutical manufacturing. Maithili Life Sciences – Where Innovation Meets Quality.